Genencor Expands Capabilities in Latin America

- Major Addition at Argentina Facility Solidifies Company's

Regional Market Penetration -



Apr 12, 2001, 01:00 ET from Genencor International, Inc.

    ROCHESTER, N.Y., April 12 /PRNewswire/ --
 Genencor International, Inc. (Nasdaq:   GCOR) announced today it has expanded
 its business capabilities in Latin America with the recent opening of its
 $6 million coater for the manufacture of granulated enzymes at its Arroyito,
 Argentina facility.  The increased capacity will allow Genencor to extend its
 full-service support of the cleaning, textile, grain and specialties markets
 to customers throughout the region.
     The company estimates the installation of its coater will triple the
 site's granular enzyme production capacity and position Genencor to capture a
 larger share of the $150-$200 million enzyme market in the region.  Currently,
 Genencor's sales in Latin America are growing at 20 percent annually.
     In addition to Genencor's increased regional manufacturing capacity, the
 company also offers sales, marketing, technical and customer service.  "We
 believe Latin America's expanding economy, large population and rich source of
 raw materials continue to make it an important market for us," said Tom
 Pekich, group vice president, Industrial Chemicals for Genencor.  "In
 particular, granulated cleaning products are a significant regional business
 focus for us and by offering a full portfolio of services, we can address
 customers' needs quickly and efficiently."
     The company acquired its Arroyito facility in 1996 through the purchase of
 the Solvay worldwide enzyme business.  Since that time, the company has used
 the facility to produce products primarily for the cleaning business.
     With approximately 100 employees at Genencor facilities in Latin America,
 the regional headquarters is located in Buenos Aires with sales support in Sao
 Paulo, Brazil and Mexico City, Mexico.  Additionally, Genencor operates eight
 manufacturing sites around the world and has sales and marketing headquarters
 for Europe and Africa in Leiden, the Netherlands and Asia Pacific in
 Singapore.
 
     About Genencor
     Genencor International is a diversified biotechnology company that
 develops and delivers innovative products into the health care, agriculture,
 industrial and consumer markets.  Using an integrated set of technology
 platforms, Genencor's products deliver innovative and sustainable solutions to
 many of the problems of everyday life.
     Genencor was established in 1982 as a joint venture between Genentech Inc.
 and Corning Incorporated.  Since its founding, Genencor has grown to become a
 leading biotechnology company, with over $315 million in annual revenues, more
 than 250 biotechnology products in commerce, and over 3,400 owned and licensed
 patents and applications.  Genencor, with more than 1,500 employees worldwide,
 has principal offices in Palo Alto, California; Rochester, New York; and
 Leiden, the Netherlands.
 
     Except for the historical information contained herein, the matters
 discussed in this press release may contain forward-looking statements which
 involve risks and uncertainties, including significant fluctuations in product
 performance depending on factors such as a dependence on the efforts of third
 parties, a new and uncertain technology employed by Genencor and its uncertain
 application to new business ventures, dependence on intellectual property
 rights, the competitive nature of Genencor's industry and risks of
 obsolescence of certain technology.  Actual results may differ materially from
 those projected.  Forward-looking statements represent the judgment of
 Genencor as of the date of this release.  Genencor disclaims, however, any
 intent or obligation to update any forward-looking statements.
 
     CONTACTS:  Investors:  Amy Giller, 650-846-7500
                Media:      Angie Blackwell, 716-256-5200
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X13620458
 
 

SOURCE Genencor International, Inc.
    ROCHESTER, N.Y., April 12 /PRNewswire/ --
 Genencor International, Inc. (Nasdaq:   GCOR) announced today it has expanded
 its business capabilities in Latin America with the recent opening of its
 $6 million coater for the manufacture of granulated enzymes at its Arroyito,
 Argentina facility.  The increased capacity will allow Genencor to extend its
 full-service support of the cleaning, textile, grain and specialties markets
 to customers throughout the region.
     The company estimates the installation of its coater will triple the
 site's granular enzyme production capacity and position Genencor to capture a
 larger share of the $150-$200 million enzyme market in the region.  Currently,
 Genencor's sales in Latin America are growing at 20 percent annually.
     In addition to Genencor's increased regional manufacturing capacity, the
 company also offers sales, marketing, technical and customer service.  "We
 believe Latin America's expanding economy, large population and rich source of
 raw materials continue to make it an important market for us," said Tom
 Pekich, group vice president, Industrial Chemicals for Genencor.  "In
 particular, granulated cleaning products are a significant regional business
 focus for us and by offering a full portfolio of services, we can address
 customers' needs quickly and efficiently."
     The company acquired its Arroyito facility in 1996 through the purchase of
 the Solvay worldwide enzyme business.  Since that time, the company has used
 the facility to produce products primarily for the cleaning business.
     With approximately 100 employees at Genencor facilities in Latin America,
 the regional headquarters is located in Buenos Aires with sales support in Sao
 Paulo, Brazil and Mexico City, Mexico.  Additionally, Genencor operates eight
 manufacturing sites around the world and has sales and marketing headquarters
 for Europe and Africa in Leiden, the Netherlands and Asia Pacific in
 Singapore.
 
     About Genencor
     Genencor International is a diversified biotechnology company that
 develops and delivers innovative products into the health care, agriculture,
 industrial and consumer markets.  Using an integrated set of technology
 platforms, Genencor's products deliver innovative and sustainable solutions to
 many of the problems of everyday life.
     Genencor was established in 1982 as a joint venture between Genentech Inc.
 and Corning Incorporated.  Since its founding, Genencor has grown to become a
 leading biotechnology company, with over $315 million in annual revenues, more
 than 250 biotechnology products in commerce, and over 3,400 owned and licensed
 patents and applications.  Genencor, with more than 1,500 employees worldwide,
 has principal offices in Palo Alto, California; Rochester, New York; and
 Leiden, the Netherlands.
 
     Except for the historical information contained herein, the matters
 discussed in this press release may contain forward-looking statements which
 involve risks and uncertainties, including significant fluctuations in product
 performance depending on factors such as a dependence on the efforts of third
 parties, a new and uncertain technology employed by Genencor and its uncertain
 application to new business ventures, dependence on intellectual property
 rights, the competitive nature of Genencor's industry and risks of
 obsolescence of certain technology.  Actual results may differ materially from
 those projected.  Forward-looking statements represent the judgment of
 Genencor as of the date of this release.  Genencor disclaims, however, any
 intent or obligation to update any forward-looking statements.
 
     CONTACTS:  Investors:  Amy Giller, 650-846-7500
                Media:      Angie Blackwell, 716-256-5200
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X13620458
 
 SOURCE  Genencor International, Inc.